Inactivation of T Cells in Platelet Concentrates by Photochemical Treatment With 150 μmol/L S-59 and UVA Light (N = 4)
Replicate . | Number of Leukocytes per mL* . | T-Cell Frequency . | Log10-Reduction of Viable T Cells-153 . | |
---|---|---|---|---|
fcontrol-151 . | ftreated-152 . | |||
1 | 1.5 × 106 | 1/22 | <1/1.1 × 107 | >5.70 |
2 | 1.3 × 106 | 1/41 | <1/1.1 × 107 | >5.43 |
3 | 4.8 × 105 | 1/43 | <1/1.1 × 107 | >5.41 |
4 | 3.4 × 106 | 1/110 | <1/1.1 × 107 | >5.00 |
Mean ± SD | 1.7 ± 1.2 × 106 | 1/39 ± 1/67 | <1/1.1 × 107 | >5.39 ± 0.29 |
Replicate . | Number of Leukocytes per mL* . | T-Cell Frequency . | Log10-Reduction of Viable T Cells-153 . | |
---|---|---|---|---|
fcontrol-151 . | ftreated-152 . | |||
1 | 1.5 × 106 | 1/22 | <1/1.1 × 107 | >5.70 |
2 | 1.3 × 106 | 1/41 | <1/1.1 × 107 | >5.43 |
3 | 4.8 × 105 | 1/43 | <1/1.1 × 107 | >5.41 |
4 | 3.4 × 106 | 1/110 | <1/1.1 × 107 | >5.00 |
Mean ± SD | 1.7 ± 1.2 × 106 | 1/39 ± 1/67 | <1/1.1 × 107 | >5.39 ± 0.29 |
*PBMCs isolated from whole blood were spiked into each of four single donor plateletpheresis units in 300 mL of 35% autologous plasma and 65% PASIII to obtain final leukocyte counts that ranged between 4.8 × 105 and 3.4 × 106 per mL. An aliquot was withdrawn from each unit for measurement of the control viable T-cell frequency by the LDA assay as described in Materials and Methods. S-59 was then added to a final concentration of 150 μmol/L and the platelet units illuminated with 1 or 3 Joules/cm2UVA. Aliquots were withdrawn after each dose of UVA for measurement of the treated viable T-cell frequency by LDA. N = 4.
fcontrol = control viable T-cell frequency.
ftreated = treated viable T-cell frequency.
The log10-reduction is calculated as log10(fcontrol/ftreated).